Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Immunotech Biopharm Ltd ( (HK:6978) ) has shared an update.
Immunotech Biopharm Ltd announced the resignation of Dr. Wang Yu from her roles as executive director, CEO, and CTO, effective June 25, 2025, due to disagreements with the board over governance issues. The board has appointed Mr. Zhang Jian as acting CEO and is actively seeking suitable candidates to fill the vacant positions, maintaining that the company’s operations remain unchanged.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, focusing on biopharmaceuticals. The company, along with its subsidiaries, operates in the biotechnology industry, primarily offering innovative medical solutions.
Average Trading Volume: 556,186
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.56B
Learn more about 6978 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue